Medical device incorporating a polymer blend

A catheter including a catheter shaft formed from a polymer blend and/or a braid. The polymer blend may include polyoxymethylene added in the dispersion phase to a polymer blend. The catheter braid can be formed from at least two continuous wires that are woven together. The catheter braid can include a proximal braid section and a distal braid section. Each of the continuous wires has a proximal diameter corresponding to the proximal braid section and a distal diameter corresponding to the distal braid section. The distal diameter of each wire can be less than the proximal diameter of that wire. A catheter braid so formed can be included in a catheter.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of co-pending U.S. patent application Ser. No. 10/875,108, filed Jun. 23, 2004, which is a continuation-in-part of co-pending U.S. patent application Ser. No. 10/645,764, filed Aug. 20, 2003, the entire disclosures of which are incorporated herein by reference.

TECHNICAL FIELD

The invention relates generally to elongate medical devices and more particularly to catheters and catheter shafts that include improved polymer blends and/or braided or other reinforcement elements.

BACKGROUND OF THE INVENTION

Reinforcing layers such as reinforcing braid layers can provide thin-walled catheters with desired resistance to kinking while retaining desirable flexibility. In some instances, it can be desirable for portions of a thin-walled catheter to be either more flexible or less flexible than other portions of the catheter. In particular, it can be desirable for a distal portion of a catheter to be more flexible, especially if the distal portion of the catheter is curved. However, a reinforcing braid layer that can provide suitable kink resistance in other portions of a catheter may not provide sufficient flexibility in the distal portion of the catheter.

A need remains for improved catheters having desirable kink resistance while being sufficiently flexible, particularly in distal portions that can be curved in use, especially when tracking dramatic bends in the vasculature of an individual.

SUMMARY OF THE INVENTION

The present invention is directed to catheters, catheter shafts, and methods for making and using the same. In some embodiments, the catheters may include a polymer blend. For example, the blend may include polyoxymethylene added in the dispersion phase to a polymer blend.

The catheters and catheter shafts can also include a braid that can be woven from continuous wires in some embodiments. A portion of each wire can have a diameter that is reduced with respect to another portion of that wire. Accordingly, an exemplary embodiment of the invention can be found in a catheter braid that is formed from at least two continuous wires that are woven together. The catheter braid can include a proximal braid section in which each of the continuous wires have a proximal diameter, and a distal braid section in which each of the continuous wires have a distal diameter. For each continuous wire, in one preferred embodiment, the distal diameter of the continuous wire is less than the proximal diameter of the continuous wire.

Another example embodiment of the invention can be found in a catheter that has a distal end and a proximal end, and a distal region that is proximate the distal end. The catheter can include an inner layer that extends from the distal end to the proximal end, and a reinforcing braid layer that can be disposed over the inner layer. The braid layer can be formed from at least two continuous wires that are woven together. The braid layer can have a proximal braid section in which each of the continuous wires has a proximal diameter, and a distal braid section in which each of the continuous wires has a distal diameter. The distal diameter of each continuous wire, in one preferred embodiment, is less than the proximal diameter of each continuous wire.

An example embodiment of the invention can also be found in a method of forming a catheter that has a distal end and a proximal end. The catheter can include an inner layer and a braid layer. The catheter can be formed by weaving together at least two continuous wires to form the braid layer. The formed braid layer distal portion is then, in a preferred embodiment, immersed in an etching solution to thin the wires to a desired reduced diameter. The resulting braid layer has a proximal section in which each of the wires has a proximal diameter and a distal section in which each of the wires has a distal diameter that is less than the proximal diameter. The braid layer, once formed, can be positioned over the inner layer.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a plan view of a catheter in accordance with an embodiment of the invention;

FIG. 2 is a cross-sectional view of the catheter of FIG. 1 taken along line 2-2;

FIG. 3 is a partially sectioned view of the catheter of FIG. 1;

FIG. 4 is a partially sectioned cutaway view of a portion of a woven braid in accordance with an embodiment of the invention;

FIG. 5 is a partially-sectioned view of a portion of a woven braid in accordance with an embodiment of the invention; and

FIG. 6 is a partially sectioned view of a distal portion of the catheter of FIG. 1.

 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.

All numeric values are herein assumed to be modified by the term “about”, whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.

The recitation of numerical ranges by endpoints includes all numbers within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).

As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.

The following description should be read with reference to the drawings wherein like reference numerals indicate like elements throughout the several views. The drawings, which are not necessarily to scale, depict illustrative embodiments of the claimed invention.

FIG. 1 is a plan view of a catheter 10 in accordance with an embodiment of the invention. The catheter 10 can be any of a variety of different catheters. In some embodiments, the catheter 10 can be an intravascular catheter. Examples of intravascular catheters include balloon catheters, atherectomy catheters, drug delivery catheters, diagnostic catheters and guide catheters. The intravascular catheter 10 can be sized in accordance with its intended use. The catheter 10 can have a length that is in the range of about 50 to about 150 centimeters, preferably in the range of about 100 to about 150 centimeters, and can have any useful diameter. As illustrated, FIG. 1 portrays a guide catheter, but the invention is not limited to such. Preferred methods of manufacture are described herein. The catheter 10 can also be manufactured using conventional techniques.

In the illustrated embodiment, the intravascular catheter 10 includes an elongate shaft 12 that has a proximal end 14 and a distal end 16. A hub and strain relief assembly 18 can be connected to the proximal end 14 of the elongate shaft 12. The hub and strain relief assembly 18 includes a main body portion 20, and a strain relief 24 that is intended to reduce kinking. The hub can also include a pair of flanges 22. The hub and strain relief assembly 18 can be of conventional design and can be attached using conventional techniques.

The elongate shaft 12 can include one or more shaft segments having varying degrees of flexibility. As illustrated, the elongate shaft 12 includes a first shaft segment 26, a second shaft segment 28 and a third shaft segment 30. In some embodiments, the elongate shaft 12 can include fewer shaft segments or only one shaft segment or can include more than three segments, depending on the flexibility requirements of a particular application.

FIG. 2 is a cross-sectional view of the elongate shaft 12, taken along the line 2-2 of FIG. 1, while FIG. 3 is a longitudinal cross-sectional view of a portion of the elongate shaft 12. The proximal portions of the elongate shaft 12, as illustrated, include an outer layer 34 and an inner layer 36, and can include a reinforcement layer 38 that is positioned between the inner layer 36 and the outer layer 34. The inner layer 36 defines a lumen 40 that extends through the elongate shaft 12. The distal portion 32 of the elongate shaft 12 will be discussed in greater detail hereinafter.

Each of the shaft segments 26, 28, 30 can have a similar construction. In particular, each of the shaft segments 26, 28, 30 can include an inner layer 36, a reinforcing layer 38 that is the same for or continuous through each of the shaft segments 26, 28, 30 and an outer layer 34 that becomes more flexible in the shaft segments 26, 28, 30 closest to the distal end 16 of the catheter 10. For example, the proximal shaft segment 26 can have an outer layer that is formed from a polymer having a hardness of 72D (Durometer), the intermediate shaft segment 28 can have an outer layer having a hardness of 68D and the distal shaft segment 30 can have an outer layer having a hardness of 46D.

Each of the shaft segments 26, 28, 30 can be sized in accordance with the intended function of the resulting catheter 10. For example, the shaft segment 26 can have a length of about 35 inches, the shaft segment 28 can have a length in the range of about 2 to 3 inches and the shaft segment 30 can have a length in the range of about 1 to 1.25 inches.

The shaft segments 26, 28, 30 can be formed of any suitable material such as a polymeric material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments, any one or all of shaft segments 26, 28, 30 can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6% LCP. This has been found to enhance torqueability.

In these and some other embodiments, any one or all of shaft segments 26, 28, 30 can include polymer blends. Some examples of suitable polymer blends include PBT and polyether-ester blends (e.g., PBT/ARNITEL®), PBT and ether or ester based copolymer blends (e.g., PBT/HYTREL® blends), POM combined with a PBT and polyether-ester blend (e.g., DELRIN®, PBT, and ARNITEL®), POM combined with a PBT and ether or ester based copolymer blend (e.g., DELRIN®, PBT, and HYTREL® blends), other polyesters (such as polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN)) blended with polyether-ester, other polyesters blended with ether or ester based copolymer, POM combined with other polyesters blended with polyether-ester, POM combined with other polyesters blended with ether or ester based copolymer, polyurethane and POM blends, and the like or any other suitable blend. In general, as the amount of POM added increases, the strength of the resultant blend increases. Some example volume percents for blends including POM, PBT, and ether or ester based copolymer such as HYTREL® (or a polyether-ester such as ARNITEL®) suitable for making any one or all of the shaft segments 26, 28, 30 are listed in Table 1 below.

TABLE 1 ether or ester based copolymer (e.g., HYTREL ®) or POM PBT polyether-ester (e.g., ARNITEL ®) 5% 55% 40% 10% 50% 40% 20% 40% 40% 30% 30% 40% 40% 20% 40% 30% 40% 30% 30% 50% 20% 30% 60% 10%

Other volume percents are contemplated. For example, some blends may include about 5% to about 90% PBT or about 5% to about 90% ether or ester based copolymer (e.g., HYTREL®) or polyether-ester (e.g., ARNITEL®).

Polymer blends such as PBT/polyether-ester and PBT/ether or ester based copolymer (for example, PBTIARNITEL® and PBT/HYTREL®) are useful for making catheter shafts such as shaft 12 as well as any other medical device that includes a polymeric structure. One reason that these blends are desirable is because of its ease in manufacturing, for example, processes such as extrusion. Adding POM to these blends may be desirable because the POM allows for stronger yet more flexible shafts to be manufactured due to the properties of POM. Typical POM blends, however, are not as easy to extrude as PBT/ARNITEL® and PBT/HYTREL®. It has been determined that adding POM in the dispersion phase to PBT/ARNITEL® or PBT/HYTREL® blends allows shafts to be manufactured (e.g., shaft 12) that have the desirable characteristics of POM (e.g., strength and flexibility) while still having the ease in manufacturing of PBT/ARNITEL® or PBT/HYTREL® blends. Accordingly, using a blend that combines POM in the dispersion phase with a PBT/ARNITEL® or PBT/HYTREL® blend allows shaft 12 to be manufactured with the desired amount of strength and flexibility, even when shaft 12 has a relatively low profile, is thin-walled, or otherwise reduced in size.

Dispersing or otherwise adding POM in the dispersion phase is understood to be dispersing POM in a molten PBT/ARNITEL® or PBT/HYTREL® blend. Alternatively, all three materials (i.e., POM/PBT/ARNITEL® or POM/PBT/HYTREL®) can be melted at the same time. Because adding POM in the dispersion phase will occur at temperature where the PBT/ARNITEL® or PBT/HYTREL® blend is melted and because the melting temperature of PBT/ARNITEL® and PBT/HYTREL® blends are higher than POM, the POM will also melt when added in the dispersion phase. However, the POM will not mix with the PBT/ARNITEL® or PBT/HYTREL® blend. Instead, the particles of molten POM will disperse in the melted PBT/ARNITEL® or PBT/HYTREL® blend. In a sense, the dispersion phase POM together with PBT/ARNITEL® or PBT/HYTREL® blend would be similar in appearance to an oil and water mix (i.e., the POM being akin to the “oil” and the PBT/ARNITEL® or PBT/HYTREL® blend being akin to the “water”). It should be noted that the amount of POM that can be added in the dispersion phase appears to be limited. For example, blends with about 50% or more POM tend to not disperse as well in PBT/ARNITEL® or PBT/HYTREL® blends. In some instances, increasing the amount of POM can result in the opposite phenomenon, i.e., the PBT/ARNITEL® or PBT/HYTREL® blend “dispersed” in the POM.

In some embodiments, adding POM in the dispersion phase may occur prior to or during an extrusion process, for example, an extrusion process suitable for manufacturing shaft 12, any or all of shaft segments 26/28/30, or any other portion of catheter 10. Thus, the molten PBT/ARNITEL® or PBT/HYTREL® blend having POM added in the dispersion phase would be extruded to form shaft 12 or any of segments 26, 28, 30. As stated above, the POM will not directly mix with the PBT/ARNITEL® or PBT/HYTREL® blend when dispersed or combined in the dispersion phase. Instead, the POM will remain as a series of particles or droplets dispersed in the PBT/ARNITEL® or PBT/HYTREL® blend. Moreover, the resultant shaft 12 will have a material composition where the POM remains dispersed in the PBT/ARNITEL® or PBT/HYTREL® blend.

Adding POM in the dispersion phase may be desirable for a number of reasons. For example, adding POM in the dispersion phase to the PBT/ARNITEL® or PBT/HYTREL® blend allows for greater flexibility in terms of adjusting the performance of the resultant shafts 12. This may make it easier, for example, to adjust the amounts of POM in the polymer blend than if the POM was blended in some other manner. In addition, by adding POM in the dispersion phase together with the PBT/ARNITEL® or PBT/HYTREL® blend, the combination is more easily extruded than other polymer blends that include POM not in the dispersion phase. These same desirable characteristics can also be realized with other combinations of dispersion phase POM and polymer blends including any of those combinations listed above. For example, dispersion phase POM can be added to PBT/ARNITEL® or PBT/HYTREL® blend.

Once the shaft 12 or shaft segments 26, 28, 30 are extruded, they may be subjected to one or more curving processes and/or other processes that include heating typically used in catheter 10 manufacturing. The curving processes may include disposing shaft 12 in a mold corresponding to the desired final curve and then heating. In some embodiments, the heating may occur at a temperature at or near the highest temperature possible that will not melt the PBT/ARNITEL® or PBT/HYTREL® blend. For example, the heating may take place at a temperature higher than the melting point of POM but lower than the melting point of the PBT/ARNITEL® or PBT/HYTREL® blend. However, a number of other temperatures and manufacturing conditions are contemplated and known in the art.

In some embodiments, the inner layer 36 can be a single piece uniform material extending over the length of the shaft 12 and can define a lumen 40 that can run the entire length of the elongate shaft 12 and that is in fluid communication with a lumen (not illustrated) extending through the hub assembly 18. The lumen 40 defined by the inner layer 36 can provide passage to a variety of different medical devices or fluids, and thus the inner layer 36 can be manufactured from or include a lubricious material to reduce friction within the lumen 40. Examples of suitable materials include polytetrafluoroethylene (PTFE), such as TEFLON®. The inner layer 36 can be dimensioned to define a lumen 40 having an appropriate inner diameter to accommodate its intended use. In some embodiments, the inner layer 36 can define a lumen 40 having a diameter in the range of about 0.04 to about 0.10 inches and can have a wall thickness of about 0.001 to about 0.02 inches.

In some embodiments, the outer layer 34 can include a portion made from a thermoplastic polymer such as a co-polyester thermoplastic polymer such as that available commercially under the ARNITEL® name. The use of an ARNITEL® polymer is described in detail below. The outer layer 34 can have an inner diameter that is about equal to the outer diameter of the inner layer 36. The outer layer 34 can have an inner diameter that is slightly greater than the outer diameter of the inner layer 36 to accommodate the thickness of the reinforcing braid layer 38. In some embodiments, the outer layer 34 can have an inner diameter in the range of about 0.0600 to about 0.0618 inches and an outer diameter in the range of about 0.0675 to about 0.0690 inches.

In some embodiments, the outer layer 34 or portions thereof can include or be filled with a radiopaque material to make the outer layer 34 or portions thereof more visible when using certain imaging techniques, for example, fluoroscopy techniques. Any suitable radiopaque material known in the art can be used. Some examples include precious metals, tungsten, barium subcarbonate powder, and the like, and mixtures thereof. In some embodiments, the polymer can include different sections having different amounts of loading with radiopaque material. For example, the outer layer 34 can include a distal section having a higher level of radiopaque material loading, and a proximal section having a correspondingly lower level of loading.

A reinforcing braid layer 38 can be positioned between the inner layer 36 and the outer layer 34. The reinforcing braid layer 38 can be formed of any suitable material, including metals and metal alloys. In some embodiments, the reinforcing braid layer 38 can include a metal wire braid (with wires that are round, flat, or other cross-sectional shape) formed of stainless steel, tungsten, gold, titanium, silver, copper, platinum, or iridium. The reinforcing braid layer 38 can also be formed from non-metallic material such as KEVLAR® (poly paraphenylene terephthalamide) fibers, LCP (liquid crystal polymer) fibers or glass fibers. In some embodiments, the reinforcing braid layer 38 can be formed of a high tensile stainless steel such as 304V stainless steel. In still other embodiments, the reinforcing braid layer 38 can be formed of a polymeric material or polymer blend such as any those disclosed herein.

In some embodiments, the reinforcing braid layer 38 can extend over substantially the entire length of the catheter 10. The reinforcing braid layer 38 can extend from a position proximate to or distal of the proximal end 14 of the elongate shaft 12 to a position proximate to or proximal of the distal end 16 of the elongate shaft 12.

As illustrated, for example, in FIG. 4, a reinforcing braid 42 can be formed of several continuous fibers. In some embodiments, the reinforcing braid 42 can be formed by weaving together two or more continuous wires over a mandrel 41. The continuous wires can be flat or round in cross-section and can be woven together in a variety of patterns. The reinforcing braid 42 can be formed by weaving together two continuous wires 44 and 46, as illustrated.

However, the invention contemplates, for example, using three continuous wires woven together in a three-over-three pattern, while other patterns such as a four-over-four, two-over-four, or even a five-over-five pattern can also be used, depending on the number of wires used. In particular, the wires can have a round cross section having a diameter of about 1.0 to about 2.0 millimeters. The braid can also be formed with flat or other non-round cross sections. If such a braid is used, the cross section reduces in dimension, such as width and height, versus diameter for a round wire.

A reinforcing braid 42 can be formed by weaving together two continuous wires 44 and 46 that have cross-sectional diameters that are at least substantially constant from a proximal end 48 of the reinforcing braid 42 to a distal end 50 of the reinforcing braid 42. As used herein, a continuous wire is a single wire that extends from one end of the braid to the other end of the braid, without splicing, welding or any other means of joining two wires together. A continuous wire can have a constant diameter across its entire length. A continuous wire can have a diameter that changes along its length. The diameter can vary continuously, or the diameter can vary step-wise.

In some embodiments, each of the continuous wires 44, 46 can have the same diameter. In other embodiments, not illustrated, it is contemplated that one continuous wire 44 can have a first constant diameter, while the second continuous wire 46 has a second constant diameter that is either greater or less than the first constant diameter.

Forming a braid 42 from continuous wires 44, 46 of constant diameter can produce a braid 42 having uniform flexibility, torque transmission and other useful performance parameters. In some embodiments, a braid 42 as illustrated in FIG. 4 can be used in part or all of a catheter 10 and forms the reinforcing braid layer 38 illustrated in the earlier Figures. In some embodiments, the braid 42 can extend from the proximal end 14 of the elongate shaft 12 to a point proximal of the distal end 16 of the elongate shaft 12.

In some embodiments, it can be desirable for a portion of the braid 42 to be more flexible than another portion of the braid 42. It may be useful for the distal portion 50 of the braid 42 to be more flexible than the proximal portion 48. For example, catheters can have a distal portion 32 that can be curved, as indicated in FIG. 6. In some embodiments, the distal portion 32 can curve in response to anatomical features encountered in use. In other embodiments, the distal portion 32 can be pre-bent or pre-curved prior to use. In order to more easily curve, it can be useful for any braid present in the distal portion 32 to be more flexible.

FIG. 5 illustrates an embodiment of a reinforcing braid 52 that can be formed, as described above with respect to FIG. 4, by weaving together two or more continuous wires 58 and 60 over a mandrel 41. The braid 52 shown in FIG. 5 has a proximal portion 54 in which each of the continuous wires 58, 60 has a proximal diameter D1 and a distal portion 56 in which each of the continuous wires 58, 60 has a distal diameter D2.

The illustrated embodiment, the distal diameter D2 is less than the proximal diameter D1. In some embodiments, the distal diameter D2 can be about one-third less than the proximal diameter D1. In a particular embodiment, the proximal diameter D1 can be about 1.5 millimeters, while the distal diameter D2 is about 1.0 millimeters. The use of diameter is illustrative of a round wire, although other shaped wire can be used with commensurate change in cross-sectional area.

As can be seen in FIG. 6, the reinforcing braid 52 can be positioned within a catheter portion 32 such that the proximal portion 54 of the braid corresponds to a more proximal section 62 of the catheter portion 32, while the distal portion 56 of the braid 52 corresponds to a curved, more distal section 64 of the catheter portion 32. As a result, the catheter portion 32 can be more flexible and supportive. In some embodiments, the reinforcing braid 52 can extend proximally to the proximal end 14 of the elongate shaft 12. In such embodiments, the proximal portion 54 forms the reinforcing braid layer 38.

The reinforcing braid 52 shown in FIG. 6 can be formed in a variety of ways. In some embodiments, the braid 52 can be formed from two continuous wires 58, 60, each having equal, constant diameters. The distal portion 56 of the braid 52 can then be subjected to a procedure that will reduce the diameter of the wires 58, 60 within the distal portion 56 of the braid 52. A number of procedures are contemplated, although electro-etching is preferred.

In other embodiments, the braid 52 can be formed from two continuous wires 58, 60 that do not have constant diameters. In particular, each of the two continuous wires 58, 60 can be formed having a first portion having a first diameter and a second portion having a second, reduced diameter. The first diameter can correspond to the proximal diameter of the continuous wires 58, 60, while the second diameter can correspond to the distal diameter of the continuous wires 58, 60. The continuous wires 58, 60 can have a gradual transition between the first and second diameters. The wires 58, 60 can also be formed having a more abrupt transition between the first and second diameters. The wires 58, 60 can be formed using any of a variety of procedures, although cold-drawing is preferred.

Once the braid 52 has been formed, it can be incorporated into a catheter 10. An inner layer 36 can be placed on a mandrel. The braid 52 can be positioned over the inner layer 36 by axially compressing the braid 52. This enlarges the inner diameter of the braid 52 and permits easy positioning of the braid 52 over the inner layer 36. Once the braid 52 has been positioned to form the reinforcing braid layer 38, an outer layer 34 can be installed if desired. The outer layer 34 can be co-extruded over the reinforcing braid layer 38, or it can be preformed and then heat shrunk into position.

In at least some embodiments, portions or all of the reinforcing braid layer 38 can include a radiopaque material. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten or tungsten alloy, molybdenum, polymer material loaded with a radiopaque filler, and the like.

In some embodiments, a degree of MI compatibility can be imparted. For example, to enhance compatibility with Magnetic Resonance Imaging (MRI) machines, it may be desirable to make the reinforcing braid layer 38, or other portions thereof, in a manner that would impart a degree of MRI compatibility. For example, the reinforcing braid layer 38 or portions thereof may be made of a material that does not substantially distort the image and create substantial artifacts, which are gaps in the image. Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. The reinforcing braid layer 38 or portions thereof may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, Elgiloy, MP35N, nitinol, and the like, and others.

An intravascular catheter 10 can optionally include a coating layer such as a lubricious coating layer over part or all of the catheter 10. Suitable lubricious polymers are well known in the art and can include hydrophilic polymers such as polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility.

It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The scope of the invention is, of course, defined in the language in which the appended claims are expressed.

Claims

1. A method for manufacturing a catheter shaft, comprising the steps of:

providing a molten blend of polybutylene terephthalate and ether or ester based copolymer;
adding polyoxymethylene in the dispersion phase to the molten blend of polybutylene terephthalate and ether or ester based copolymer to define a polymer blend; and
extruding a shaft member from the polymer blend.

2. The method of claim 1, wherein the polymer blend includes about 5% to about 40% by volume of polyoxymethylene.

3. The method of claim 2, wherein the polymer blend includes about 5% to about 90% by volume polybutylene terephthalate.

4. The method of claim 2, wherein the polymer blend includes about 5% to about 90% by volume ether or ester based copolymer.

5. The method of claim 1, wherein the molten blend of polybutylene terephthalate and ether or ester based copolymer includes polyether-ester.

6. The method of claim 1, further comprising disposing a braid on the shaft member.

7. The method of claim 6, wherein the braid has a proximal portion and a distal portion different from the proximal portion.

8. The method of claim 6, wherein the braid is formed from at least two continuous wires woven together.

9. The method of claim 8, wherein the braid includes a proximal braid section in which each of the continuous wires has a proximal cross-sectional area and a distal braid section in which each of the continuous wires has a distal cross-sectional area, and wherein for each continuous wire, the distal cross-sectional area is less than the proximal cross-sectional area.

Referenced Cited
U.S. Patent Documents
2437542 March 1948 Krippendorf
2472483 June 1949 Krippendorf
2472484 June 1949 Krippendorf
2472485 June 1949 Krippendorf
3416531 December 1968 Edwards
3463197 August 1969 Slade
3481368 December 1969 Vansickle et al.
3485234 December 1969 Stevens
3612058 October 1971 Ackerman
3924632 December 1975 Cook
4210478 July 1, 1980 Shoney
4279252 July 21, 1981 Martin
4321226 March 23, 1982 Markling
4385635 May 31, 1983 Ruiz
4419095 December 6, 1983 Nebergall et al.
4425919 January 17, 1984 Alston, Jr. et al.
4430083 February 7, 1984 Ganz et al.
4447239 May 8, 1984 Krütten
4484586 November 27, 1984 McMickle et al.
4495134 January 22, 1985 Ouchi et al.
4516970 May 14, 1985 Kaufman et al.
4516972 May 14, 1985 Samson
4531943 July 30, 1985 Van Tassel et al.
4563181 January 7, 1986 Wijayarathna et al.
4571240 February 18, 1986 Samson et al.
4577543 March 25, 1986 Wilson
4588399 May 13, 1986 Nebergall et al.
4636346 January 13, 1987 Gold et al.
4639252 January 27, 1987 Kelly et al.
4657024 April 14, 1987 Coneys
4665604 May 19, 1987 Dubowik
4690175 September 1, 1987 Ouchi et al.
4705511 November 10, 1987 Kocak
4735620 April 5, 1988 Ruiz
4737153 April 12, 1988 Shimamura et al.
4764324 August 16, 1988 Burnham
4817613 April 4, 1989 Jaraczewski et al.
4838879 June 13, 1989 Tanabe et al.
4842590 June 27, 1989 Tanabe et al.
4863442 September 5, 1989 DeMello et al.
4898591 February 6, 1990 Jang et al.
4899787 February 13, 1990 Ouchi et al.
4904431 February 27, 1990 O'Maleki
4981478 January 1, 1991 Evard et al.
4985022 January 15, 1991 Fearnot et al.
5017259 May 21, 1991 Kohsai
5019057 May 28, 1991 Truckai
5037404 August 6, 1991 Gold et al.
5045072 September 3, 1991 Castillo et al.
5057092 October 15, 1991 Webster, Jr.
5069674 December 3, 1991 Fearnot et al.
5078702 January 7, 1992 Pomeranz
5160559 November 3, 1992 Scovil et al.
5163431 November 17, 1992 Griep
5176660 January 5, 1993 Truckai
5178158 January 12, 1993 de Toledo
5180376 January 19, 1993 Fischell
5184627 February 9, 1993 de Toledo
5190520 March 2, 1993 Fenton, Jr. et al.
5217440 June 8, 1993 Frassica
5217482 June 8, 1993 Keith
5218037 June 8, 1993 Orikasa et al.
5219335 June 15, 1993 Willard et al.
5221270 June 22, 1993 Parker
5221372 June 22, 1993 Olson
5222949 June 29, 1993 Kaldany
5226899 July 13, 1993 Lee et al.
5234416 August 10, 1993 Macaulay et al.
5248305 September 28, 1993 Zdrahala
5254107 October 19, 1993 Soltesz
5258160 November 2, 1993 Utsumi et al.
5279596 January 18, 1994 Castaneda et al.
5306252 April 26, 1994 Yuteri et al.
5308342 May 3, 1994 Sepetka et al.
5318032 June 7, 1994 Lonsbury et al.
5334169 August 2, 1994 Brown et al.
5335305 August 2, 1994 Kosa et al.
5353808 October 11, 1994 Viera
5358493 October 25, 1994 Schweich, Jr. et al.
5403292 April 4, 1995 Ju
5417981 May 23, 1995 Endo et al.
5423773 June 13, 1995 Jimenez
5423774 June 13, 1995 Fischell et al.
5441489 August 15, 1995 Utsumi et al.
5445624 August 29, 1995 Jimenez
5451209 September 19, 1995 Ainsworth et al.
5453099 September 26, 1995 Lee et al.
5454795 October 3, 1995 Samson
5484565 January 16, 1996 Larsen et al.
5496294 March 5, 1996 Hergenrother et al.
5499973 March 19, 1996 Saab
5509910 April 23, 1996 Lunn
5514108 May 7, 1996 Stevens
5531721 July 2, 1996 Pepin et al.
5533987 July 9, 1996 Pray et al.
5538513 July 23, 1996 Okajima
5545151 August 13, 1996 O'Connor et al.
5554139 September 10, 1996 Okajima
5569218 October 29, 1996 Berg
5569220 October 29, 1996 Webster, Jr.
5584821 December 17, 1996 Hobbs et al.
5599319 February 4, 1997 Stevens
5599326 February 4, 1997 Carter
5603705 February 18, 1997 Berg
5624617 April 29, 1997 Sorabella et al.
5639409 June 17, 1997 van Muiden
5658263 August 19, 1997 Dang et al.
5658264 August 19, 1997 Samson
5662622 September 2, 1997 Gore et al.
5664580 September 9, 1997 Erickson et al.
5667499 September 16, 1997 Welch et al.
5674208 October 7, 1997 Berg et al.
5676659 October 14, 1997 McGurk
5695483 December 9, 1997 Samson
5702373 December 30, 1997 Samson
5711909 January 27, 1998 Gore et al.
5725513 March 10, 1998 Ju et al.
5728079 March 17, 1998 Weber et al.
5730733 March 24, 1998 Mortier et al.
5738742 April 14, 1998 Stevens
5755704 May 26, 1998 Lunn
5772609 June 30, 1998 Nguyen et al.
5782809 July 21, 1998 Umeno et al.
5782811 July 21, 1998 Samson et al.
5792124 August 11, 1998 Horrigan et al.
5795341 August 18, 1998 Samson
5827242 October 27, 1998 Follmer et al.
5836926 November 17, 1998 Peterson et al.
5876386 March 2, 1999 Samson
5885207 March 23, 1999 Iwasaka
5891112 April 6, 1999 Samson
5891114 April 6, 1999 Chien et al.
5899892 May 4, 1999 Mortier et al.
5906605 May 25, 1999 Coxum
5906606 May 25, 1999 Chee et al.
5911715 June 15, 1999 Berg et al.
5938653 August 17, 1999 Pepin
5947925 September 7, 1999 Ashiya et al.
5947939 September 7, 1999 Mortier et al.
5947940 September 7, 1999 Beisel
5951539 September 14, 1999 Nita et al.
5964971 October 12, 1999 Lunn
5972143 October 26, 1999 Stevens
6042578 March 28, 2000 Dinh et al.
6045734 April 4, 2000 Luther et al.
6053904 April 25, 2000 Scribner et al.
6090099 July 18, 2000 Samson et al.
6099499 August 8, 2000 Ciamacco, Jr.
6099561 August 8, 2000 Alt
6102890 August 15, 2000 Stivland et al.
6113579 September 5, 2000 Eidenschink et al.
6139510 October 31, 2000 Palermo
6143013 November 7, 2000 Samson et al.
6152911 November 28, 2000 Giannoble
6152912 November 28, 2000 Jansen et al.
6159187 December 12, 2000 Park et al.
6165163 December 26, 2000 Chien et al.
6171295 January 9, 2001 Garabedian et al.
6186978 February 13, 2001 Samson et al.
6197014 March 6, 2001 Samson et al.
6212422 April 3, 2001 Berg et al.
6217565 April 17, 2001 Cohen
6245068 June 12, 2001 Olson et al.
6251092 June 26, 2001 Qin et al.
6258080 July 10, 2001 Samson
6284333 September 4, 2001 Wang et al.
6290692 September 18, 2001 Klima et al.
6296631 October 2, 2001 Chow
6315757 November 13, 2001 Chee et al.
6322534 November 27, 2001 Shkolnik
6355027 March 12, 2002 Le et al.
6358238 March 19, 2002 Sherry
6368316 April 9, 2002 Jansen et al.
6387121 May 14, 2002 Alt
6443925 September 3, 2002 Schaible et al.
6451026 September 17, 2002 Biagtan et al.
6458867 October 1, 2002 Wang et al.
6464684 October 15, 2002 Galdonik
6465067 October 15, 2002 Wang et al.
6485457 November 26, 2002 Hisamatsu et al.
6500147 December 31, 2002 Omaleki et al.
6503353 January 7, 2003 Peterson et al.
6508804 January 21, 2003 Sarge et al.
6508805 January 21, 2003 Garabedian et al.
6511462 January 28, 2003 Itou et al.
6540743 April 1, 2003 Olson et al.
6562022 May 13, 2003 Hoste et al.
6575958 June 10, 2003 Happ et al.
6635047 October 21, 2003 Forsberg
6648854 November 18, 2003 Patterson et al.
6669886 December 30, 2003 Willard
6709429 March 23, 2004 Schaefer et al.
7112298 September 26, 2006 Kampa et al.
20030009184 January 9, 2003 Pepin
20030055402 March 20, 2003 Zhou
20030135114 July 17, 2003 Pacetti et al.
20030167051 September 4, 2003 Zhou
20050043713 February 24, 2005 Zhou
Foreign Patent Documents
0 180 348 May 1986 EP
0 277 366 August 1988 EP
0 382 974 August 1990 EP
0 473 045 August 1990 EP
0 555 088 August 1993 EP
0 732 117 September 1996 EP
0 810 003 December 1997 EP
WO 92/15356 September 1992 WO
WO 96/33763 October 1996 WO
WO 98/50097 November 1998 WO
WO 00/43061 July 2000 WO
WO 01/10492 February 2001 WO
WO 01/54761 August 2001 WO
WO 03/028783 April 2003 WO
Other references
  • Ahmed, Salmaan et al., “Magnetic Resonance Imaging Safety: Implications for Cardiovascular Patients,” Journal of Cardiovascular Magnetic Resonance, vol. 3, No. 3 (2001), pp. 171-182.
  • Aleksandrovic, Vesna et al, “Synthesis and Characterization of Thermoplastic Copolyester Elastomers Modified with Fumaric Moieties,” J. Serb. Chem. Soc., vol. 66, No. 3 (2001) pp. 139-152.
  • Brochure—“Arnitel® Copolyester Elastomers, General Information on Applications and Properties,” © Jun. 2001 DMS Engineering Plastics, 24 pages.
  • Brochure—“Arnitel® Copolyester Elastomers, Product Characteristics” © Jan. 2001 DSM Engineering Plastics, Jan. 2001, 6 pages.
  • Brochure—“DuPont Hytrel Polyester Elastomer Product and Properties Guide” dated on or before Jun. 23, 2004, 12 pages.
  • Chapter 7 and Chapter 10, Introduction to Magnetic Properties, Electrical and Magnetic Properties of Metals, ASM International® , printed on or before May 16, 2002, pp. 193-195 and 263-270.
  • Kolobow et al., “A New Thin-Walled Nonkinking Catheter for Peripheral Vascular Cannulation,” Surgery, vol. 68, No. 4, Oct. 1970, pp. 625-629.
  • Schröder, Chris, “New Developments in Co-polyester Based thermoplastic Elastomers,” Source Unknown, dated on or before Jun. 23, 2004, 5 pages.
  • Schueler, Beth A. et al., “MRI Compatibility and Visibility Assessment of Implantable Medical Devices,” Journal of Magnetic Resonance Imaging, vol. 9. (1999) pp. 596-603.
  • Spees, William M. et al., “Water Proton MR Properties of Human Blood at 1.5 Tesla: Magnetic Susceptibility, T1, T, T*2, and Non-Lorentzian Signal Behavior,” Magnetic Resonance in Medicine, vol. 45 (2001) pp. 533-542.
  • Teweldemedhin, Z.S. et al., “Magnetic Susceptibility Measurements of Solids,” source unknown, dated on or before Jan. 6, 2000, 8 pages.
Patent History
Patent number: 8251976
Type: Grant
Filed: Oct 27, 2009
Date of Patent: Aug 28, 2012
Patent Publication Number: 20100043959
Assignee: Boston Scientific Scimed, Inc. (Maple Grove, MN)
Inventor: Pu Zhou (Maple Grove, MN)
Primary Examiner: Manuel Mendez
Attorney: Seager, Tufte & Wickhem, LLC
Application Number: 12/606,488
Classifications
Current U.S. Class: Flexible Catheter Or Means (e.g., Coupling) Used Therewith (604/523); Hollow Preform (264/171.12)
International Classification: A61M 25/00 (20060101);